Cardiovascular Medicine and Prevention Update for Primary Care 2021
Practice Gaps and Needs
Cardiovascular medicine is a vast area of clinical practice with continually evolving and developing research, guidelines, best practices, and new medication and technology. Primary care teams including physicians, advanced practice providers and pharmacists are challenged to optimally manage a multitude of diseases involving the cardiovascular system including the failing heart, the heart with abnormal arrhythmias and the circulation affected by abnormal cholesterol metabolism and hypertension. National guidelines that help these care teams establish best practices continue to be refined every year. The implications of these new guidelines and new medications and their utilization will be a major topic of discussion.
The implications of stress test results in patients with coronary artery disease (CAD) will be addressed. We will focus on updated prevention measures including management of hypertension, a long-standing risk factor for CAD, as well as the perplexing topic of diets and new drugs that might improve outcomes for patients with metabolic syndrome.
Accurate diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation and flutter, is a common area of concern for primary care physicians and advanced practice providers. Although common, some drug therapies have significant toxicities. Updated information regarding cardioversion, a common method of treating atrial arrhythmias, and its effectiveness will be reviewed as well as ablation therapy. Ablation therapy is now a more mature therapeutic option, though data regarding the longitudinal effectiveness of this therapy has altered the perception as to who is a good candidate for this treatment modality. Additionally, we will address the role of SGLT2 inhibitors. Finally, we will examine current and evolving information regarding COVID in cardiovascular medicine.
This activity is designed for physicians, nurse practitioners, physician assistants, pharmacists, nurses and other allied health personnel working in the field of primary care who treat and evaluate patients in need of prevention and treatment of cardiovascular diseases.
Elements of Competence
This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties' areas of patient care and procedural skills, medical knowledge, and interprofessional and communication skills.
This activity focuses on the Interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.
This activity also focuses on the Center for Advancement of Pharmacy Education (CAPE) competency of interprofessional collaboration.
At the conclusion of the activity, the healthcare team will be able to:
- Identify best practices for the treatment of hypertension both in the elderly and across the entire age spectrum.
- Discuss implications of patient initiated activities such as self-directed diets.
- Assess the implications of the new guidelines for treatment of cholesterol and various lipid abnormalities in children.
- Summarize new guidelines and identify best practices for drug and device therapy for patients with atrial arrhythmias.
- Outline new and evolving information on the role of SGLT2 inhibitors.
- Discuss implications of stress test results in patients with coronary artery disease (CAD).
- Examine current and evolving data and research pertaining to COVID in cardiovascular medicine.
Friday, March 20, 2020
|7:50||Welcome and Intro|
Peter Rahko, MD
|8:00||Session I: Prevention|
Moderators: Adam Gepner, MD & Matthew Tattersall, DO, MS
|8:05||Pearls and Pitfalls for Managing Hypertension in Primary Care|
James Stein, MD
|8:30||Fact Checking: 2021 Diet Trends|
Jane Pearson, MD
|8:55||Screening and Treating Lipids in Children and Adolescents|
Amy Peterson, MD
Stein, Pearson, Peterson & Clinical Nutritionist: Kavita Poddar, PhD, RD, CD
|10:05||Session II: Electrophysiology|
Moderators: Craig January, MD, PhD & Daniel Modaff, MD
|10:10||Antiarrhythmic Drugs: What to Watch For?|
Zachary Goldberger, MD
|10:35||Cardioversion: A Shocking Alternative|
Amanda Breuer, PA-C
|11:00||Ablation Therapy: Who Needs It?|
Jennifer Wright, MD
Goldberger, Breuer, Wright
|12:00||LUNCH BREAK & VIRTUAL EXHIBITS|
|1:00||Session III: Hot Topics in Cardiology|
Moderators: Chuck Stone, MD & Peter Rahko, MD
|1:05||SGLT2 Inhibitors and Cardiovascular Disease: A New Frontier|
Ted Berei, PharmD
|1:30||Eliminating the Stress from Stress Tests: Outpatient Non-Invasive Evaluation of Coronary Artery Disease|
Nicole Reilly, MD
|1:55||COVID in Cardiovascular Medicinie|
Brad Ternus, MD
Berei, Reilly, Ternus
Peter Rahko, MD
This is a virtual conference (central time). Please see the Program for further information.
A link will be sent to participants prior to the activity start date.
*Peter Rahko, MD, Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director, Adult Echocardiography Laboratory
*Zachary Goldberger, MD, Associate Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH
PRESENTERS, MODERATORS & PLANNERS
*Terese Bailey, BS, Senior Outreach Specialist, Office of Continuing Professional Development in Medicine and Public Health, UW SMPH
*Ashley Bartlett, BS, Administrative Program Specialist, Cardiovascular Medicine Division, UW SMPH
*Mark Beamsley, MD, Clinical Associate Professor of Medicine, Department of Family Medicine and Community Health, UW SMPH
Ted Berei, PharmD, Clinical Pharmacist, UWHC
Amanda Breuer, PA-C, Electrophysiology, Department of Medicine, UW SMPH
*Adam Gepner, MD, Cardiologist, William S. Middleton Memorial Veterans Hospital; Clinical Adjunct Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH
*Todd Goldman, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director of Adult Echocardiography, William S. Middleton Memorial Veterans Hospital
*Joan Hermsen, DNP, APNP, Heart Failure & Transplant Cardiology, APP Supervisor, Cardiovascular Medicine Division, UW SMPH
*Craig January, MD, PhD, Professor of Medicine, Cardiovascular Medicine Division, UW SMPH; Director, Heart Station
*Maryl Johnson, MD, Professor of Medicine (CHS), Heart Failure and Transplant Cardiology, Cardiovascular Medicine Division, UW SMPH
*Ali Kamps, PA-C, Electrophysiology, Cardiovascular Medicine Division, UW SMPH
*Karen Kopacek, MS, RPh, Associate Professor (CHS), Associate Dean for Student Affairs, UW-Madison School of Pharmacy
*Miguel Leal, MD, Associate Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH; Director, Electrophysiology & Arrhythmia Service; Director, Cardiovascular Medicine & Electrophysiology Fellowship Programs
Daniel Modaff, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH
Jane Pearson, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH
Amy Peterson, MD, Associate Professor of Pediatrics and Medicine (CHS), Pediatric Cardiology, UW SMPH
Kavita Poddar, PhD, RD, CD, Clinical Nutritionist, UWHC
Nicole Reilly, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH
James Stein, MD, Robert Turell Professor in Cardiovascular Research, Cardiovascular Medicine Division, UW SMPH; Director, Preventive Cardiology Program and Advanced Hypertension Program
*Charles Stone, MD, Associate Professor of Medicine and Radiology, Cardiovascular Medicine Division, UW SMPH; Director, UW Health Nuclear Cardiology; Director UW Health Regional Services
Matthew Tattersall, DO, MS, Assistant Professor of Medicine (CHS), Cardiovascular Medicine Division, UW SMPH
Brad Ternus, MD, Clinical Assistant Professor of Medicine, Cardiovascular Medicine Division, UW SMPH
*Kathleen Walsh, DO, Clinical Associate Professor of Medicine, Cardiovascular Medicine and Geriatrics Divisions, UW SMPH; Associate Director, UW Faint and Fall Clinic
Jennifer Wright, MD, Clinical Associate Professor of Medicine, UW SMPH
*= Planning Committee Member
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Financial Relationship Disclosures
Discussion of Unlabeled/
Unapproved uses of drugs/devices in presentation?
|Terese Bailey, BS||Planner||No relevant financial relationships to disclose||No|
|Ashley Bartlett, BS||Planner||No relevant financial relationships to disclose||No|
|Mark Beamsley, MD||Planning Committee||No relevant financial relationships to disclose||No|
|Ted Berei, PharmD||Presenter||No relevant financial relationships to disclose||Yes|
|Amanda Breuer, PA-C||Presenter|
|Adam Gepner, MD||Planning Committee & Moderator||Beam Health Care & Telehealth (Contractor)||No|
|Zachary Goldberger, MD||Course Co-Director & Presenter||No relevant financial relationships to disclose||No|
|Todd Goldman, MD||Planning Committee|
|Joan Hermsen, DNP, APNP||Planning Committee|
|Craig January, MD, PhD||Planning Committee & Moderator|
|Maryl Johnson, MD||Planning Committee||American Board of Internal Medicine (Contractor); NHLBI (Contractor); Medtronic (Contractor); CVS (Contractor)||No|
|Ali Kamps, PA-C||Planning Committee||No relevant financial relationships to disclose||No|
|Karen Kopacek, MS, RPh||Planning Committee||No relevant financial relationships to disclose||No|
|Miguel Leal, MD||Planning Committee|
|Daniel Modaff, MD||Moderator||No relevant financial relationships to disclose||No|
|Jane Pearson, MD||Presenter|
|Amy Peterson, MD||Presenter|
|Kavita Poddar, PhD, RD, CD||Panel Member||No relevant financial relationships to disclose||No|
|Peter Rahko, MD||Course Co-Director & Moderator|
|Nicole Reilly, MD||Presenter||No relevant financial relationships to disclose||No|
|James Stein, MD||Presenter||Eli Lilly and Company & Silence Therapeutics (Contractor)||No|
|Charles Stone, MD||Planning Committee & Moderator|
|Matthew Tattersall, DO, MS||Moderator|
|Brad Ternus, MD||Presenter|
|Kathleen Walsh, DO||Planning Committee||No relevant financial relationships to disclose||No|
|Jennifer Wright, MD||Presenter||No relevant financial relationships to disclose||No|
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
Accreditation Council of Pharmacy Education (ACPE)
The University of Wisconsin–Madison ICEP designates this knowledge-based activity for a maximum of 5.50 hours/0.55 CEUs of CPE credit. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number (UAN) JA0000358-0000-21-046-L01-P, 5.50 hours (0.55 CEUs)
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 5.50 ANCC contact hours. ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate to meet the needs of advanced practice nurses.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. Iowa Board of Nursing accepts ANCC contact hours for nursing continuing education requirements.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.55 continuing education units (CEUs) or 5.50 hours.
American Academy of Family Physicians (AAFP)
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
Academy of Nutrition and Dietetics
Application for credit has been filed.
University of Wisconsin School of Medicine and Public Health
Department of Medicine, Division of Cardiovascular Medicine
University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP)
- 5.50 AAPA Category 1 CME
- 5.50 ACPE Contact Hours - Pharmacist
- 5.50 ACPE: Disease State Management/Drug Therapy – Pharmacist
- 5.50 AMA PRA Category 1 Credit™
- 5.50 AAFP Credits
- 5.50 ANCC Contact Hours
- 0.00 ANCC Pharmacotherapy Contact Hours
- 5.50 CDR CPEUs
- 5.50 University of Wisconsin–Madison Continuing Education Hours
- 5.50 Approved for AMA PRA Category 1 Credit™
Check back periodically for an up-to-date list of exhibitors.
Click on the link to enter their virtual "booth."
Exhibitor "drop in" times: April 16, 2021, 12:00-1:00 pm
REGISTRATION DEADLINE: April 16, 2021
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to firstname.lastname@example.org. Cancellation requests received at least 96 hours (April 12, 2021) prior to the conference will allow a full refund except for the $25 nonrefundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.
QUESTIONS ABOUT REGISTRATION
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Conference materials will be posted on Wednesday, April 14, 2021.
FOR FURTHER INFORMATION
For conference information or details regarding exhibit booths please contact Ashley Bartlett at email@example.com
Computer, tablet, or smartphone with audio sharing capabilities.